News
The ATOMIC study: atezolizumab plus FOLFOX chemotherapy significantly improves disease-free survival and reduces the risk of recurrence in stage III colon cancer
A new study - the ATOMIC trial - has found that adding the immunotherapy atezolizumab to standard chemotherapy (FOLFOX) significantly improves outcomes for people with...
Ultraprocessed Food Consumption and Risk of Early-Onset Colorectal Cancer Precursors Among Women
November 2025 A new study published in JAMA Oncology found that women who eat more ultraprocessed foods (UPFs) such as packaged snacks, sugary drinks, and...
Microplastics in the Gut Linked to Colorectal Cancer-Like Patterns
November 2025 New research from the microONE project (CBmed GmbH, Austria) suggests that microplastics may impact gut health by altering...
Rectal Bleeding Identified as Key Predictor of Early-Onset Colorectal Cancer
November 2025 A recent study presented at the American College of Surgeons Clinical Congress 2025 highlights rectal bleeding as a...
Do GLP-1 Medications Affect Cancer Risk?
The use of glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications, originally developed for the management of type 2 diabetes,...
Lower the Colorectal Cancer Screening Age to 45: A Call to Action for Canada
At Colorectal Cancer Canada, we are proud to launch a new national advocacy campaign through our Never Too Young (N2Y)...
Get social
The ATOMIC study: atezolizumab plus FOLFOX chemotherapy significantly improves disease-free survival and reduces the risk of recurrence in stage III colon cancer
A new study - the ATOMIC trial - has found that adding the immunotherapy atezolizumab to standard chemotherapy (FOLFOX) significantly improves outcomes for people with...
Ultraprocessed Food Consumption and Risk of Early-Onset Colorectal Cancer Precursors Among Women
November 2025 A new study published in JAMA Oncology found that women who eat more ultraprocessed foods (UPFs) such as packaged snacks, sugary drinks, and...
Microplastics in the Gut Linked to Colorectal Cancer-Like Patterns
November 2025 New research from the microONE project (CBmed GmbH, Austria) suggests that microplastics may impact gut health by altering...
Rectal Bleeding Identified as Key Predictor of Early-Onset Colorectal Cancer
November 2025 A recent study presented at the American College of Surgeons Clinical Congress 2025 highlights rectal bleeding as a...
Do GLP-1 Medications Affect Cancer Risk?
The use of glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications, originally developed for the management of type 2 diabetes,...
Lower the Colorectal Cancer Screening Age to 45: A Call to Action for Canada
At Colorectal Cancer Canada, we are proud to launch a new national advocacy campaign through our Never Too Young (N2Y)...
